Clinical Center of Montenegro, Institute for Children’s Diseases, Podgorica, Montenegro + University of Montenegro Faculty of Medicine, Podgorica, Montenegro
Auto-generated profile, based on publicly available information
Željka Rogač
Clinical Center of Montenegro, Institute for Children’s Diseases, Podgorica, Montenegro + University of Montenegro Faculty of Medicine, Podgorica, Montenegro
Objective: Complete or major symptoms of ADHD are often present in epilepsy. This study evaluated inattention and hyperactivity symptoms over the first 6 months in newly diagnosed pediatric epilepsy without comorbid ADHD. Method: Children and adolescents with newly diagnosed epilepsy were followed for 6 months after starting antiseizure medications. The Nisonger Child Behavior Rating Form (NCBRF), Adverse Event Profile (AEP), and the Revised Wechsler Intelligence Scale for Children were used. Results: There was a marked increase in attention difficulties while a moderate increase in hyperactivity levels. AEP scores, changes in non-verbal aspects of intelligence, levels of hyperactivity at the follow-up, and attention at baseline were significant predictors for inattention. In contrast, only levels of hyperactivity at the baseline and inattention at the follow-up were significant predictors for hyperactivity. Conclusion: Significant inattention and hyperactivity levels originated 6 months after the diagnosis of epilepsy and starting antiseizure medication.
To determine changes in the quality of life associated with epilepsy in school-age children with newly diagnosed uncomplicated epilepsy over the first six months after diagnosis to find points relevant for the early prevention of deterioration in quality of life. This prospective follow-up study, performed in University Children's Hospital in Belgrade, enrolled 60 school-aged children with recently diagnosed epilepsy, along with their parents. The respondents completed the Children with Epilepsy Quality of Life immediately following the diagnosis of epilepsy and six months later. Significant decline was observed in the domains related to intrapersonal/emotional relationships by both children (P<0.001) and their parents (P=0.03), and in the need to keep epilepsy a secret as observed by parents (P = 0.04). Significant improvement was found in the Interpersonal/Social domain as rated by parents (P=0.001). Total quality-of-life scores, as assessed by children and parents, did not change significantly. Bearing in mind that stigma and intrapersonal struggles are the major factors affecting the quality of life in children with epilepsy, psychological and social support is highly recommended in the first six months following an epilepsy diagnosis. Since intrapersonal relationships improved over six months, compensating for other deteriorations in the quality of life, children with epilepsy should be encouraged to socialize with their peers and to join organizations and actions that encourage social contact.
1 January 2025 in Srpski arhiv za celokupno lekarstvo
Introduction/Objective. Previously, we have shown that six months after initiating monotherapy in school-age children with new-onset uncomplicated epilepsy, minimal changes in cognition and significant symptoms of anxiety, depression, and behavioral changes were observed. In the same group of children, we aimed to show and compare the effects of the most commonly used anti-seizure medications (ASMs) on cognition, psychopathological symptoms, and behavior, to provide guidance in selecting appropriate ASMs. Methods. Children with newly diagnosed epilepsy completed the Revised Wechsler Intelligence Scale for Children in Serbian (REVISK), the Revised Child Anxiety and Depression Scale (RCADS), and the Nisonger Child Behavior Rating Form (NCBRF), immediately after initiating therapy and six months later, at the University Children?s Clinic in Belgrade. Results. Scores on the social phobia subscale increased significantly in children on lamotrigine monotherapy compared to other ASMs, as well as on the separation anxiety disorder subscale and total internalizing symptoms in patients on ethosuximide (p < 0.05). The scores on the depressive disorder subscale increased significantly in those on ethosuximide, followed by levetiracetam (p < 0.05). There is no statistically significant difference in the change of other RCADS scores and REVISK and NCBRF scores between different types of ASMs during the six months (p < 0.05). Conclusion. The subtle influence of the tested ASMs was already present during the first six months of treatment. Valproate led to a trend of improved cognition, while ethosuximide and levetiracetam contributed to worsening internalizing symptoms during the first six months.
19 November 2019 in Facta Universitatis. Series: Physical Education and Sport
People with epilepsy (PWE) face numerous difficulties. Because of the complicity of the disease, a thorough treatment of those patients requires a multidisciplinary approach. One of the important aspects such approach should take into account is the quality of life of PWE. Apart from the pharmacological solutions, it is necessary to further search for non-pharmacological ones. In addition to raising education and level of awareness this means dealing with physical activity due to numerous benefits. Sometimes doctors themselves do not know how to assess risks and benefits, and in order to protect the patients, advise that it is best not to engage in any sport, thereby contributing to the vicious circle - fear - stigma - poor quality of life. The aim of this paper is to unify the experiences of various researchers on this topic, to point out the many difficulties that PWE meet, and to define guidelines in the workplace. We will try to answer a commonly posed question which sometimes in practice remain unclarified, that is - whether epilepsy patients should be involved in sports, if so - which sport, and what intensity of physical activity would be allowed, can they participate in the competitions. In order to provide patients with a decent life quality it is necessary to work on the education of patients and doctors, and the society as well. While giving recommendations, it is necessary to follow the guidelines, among which are the most comprehensive ones were created by the International League Against Epilepsy (ILAE) in 2016.